The week in review

The latest on GLP-1 listings, NSW broadens nasal FluMist access and a potential pharmacy payment for diphtheria vaccination were among our readers’ picks this week A pricing agreement is needed before glucagon-like peptide-1 (GLP-1) medications can be listed on the Pharmaceutical Benefits Scheme (PBS) for weight loss, Minister for Health, Disability and Ageing, Mark Butler says.   Responding